Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 18385778)

  • 1. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
    Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
    Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
    Murphy C; Hawkes E; Chionh F; Chong G
    J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of Castleman's disease with HAART in two HIV-infected patients.
    Lanzafame M; Carretta G; Trevenzoli M; Lazzarini L; Vento Ercole Concia S
    J Infect; 2000 Jan; 40(1):90-1. PubMed ID: 10762119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.
    Powles T; Stebbing J; Bazeos A; Hatzimichael E; Mandalia S; Nelson M; Gazzard B; Bower M
    Ann Oncol; 2009 Apr; 20(4):775-9. PubMed ID: 19179554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.
    Ortega L; Cooper CJ; Otoukesh S; Mojtahedzadeh M; Didia CS; Torabi A; Nahleh Z
    Rare Tumors; 2014 Jul; 6(3):5480. PubMed ID: 25276327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of multicentric Castleman's disease accompanying myeloma with bortezomib.
    Khan AA; Siraj F; Bhargava M; Aggarwal S
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23264156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy.
    Bottieau E; Colebunders R; Schroyens W; Van Droogenbroeck J; De Droogh E; Depraetere K; De Raeve H; Van Marck E
    Acta Clin Belg; 2000; 55(2):97-101. PubMed ID: 10881375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma herpesvirus-associated Castleman's disease with POEMS syndrome.
    Kim DE; Kim HJ; Kim YA; Lee KW
    Muscle Nerve; 2000 Mar; 23(3):436-9. PubMed ID: 10679723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic multicentric Castleman's disease: a systematic literature review.
    Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
    Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
    Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
    Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifty years of multicentric Castleman's disease.
    Waterston A; Bower M
    Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
    Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
    Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.
    Bollen J; Polstra A; Van Der Kuyl A; Weel J; Noorduyn L; Van Oers M; Cornelissen M
    BMC Blood Disord; 2003 Dec; 3(1):3. PubMed ID: 14670091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
    Aoki Y; Tosato G
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
    Fernando I; Scott G
    Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
    Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
    WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated multicentric Castleman's disease.
    Naime Fde F; Fakhouri F; Martins CS; Couto WJ
    Rare Tumors; 2012 Jun; 4(3):e40. PubMed ID: 23087796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
    Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
    Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.